Mary Wallace
Question:60 Miss M. Wallace asked the Minister for Health the budgetary allocation he has reserved for expanding breast cancer screening during the next 12 months. [7800/95]
Vol. 452 No. 2
60 Miss M. Wallace asked the Minister for Health the budgetary allocation he has reserved for expanding breast cancer screening during the next 12 months. [7800/95]
61 Miss M. Wallace asked the Minister for Health the steps, if any, he is taking to develop a specific plan for the direct targeting of women for breast cancer screening. [7801/95]
62 Miss M. Wallace asked the Minister for Health if his attention has been drawn to the fact that women in their late 20s who are referred by their doctor for a mammogram are frequently refused the procedure; and if he will make a statement on the matter. [7802/95]
66 Miss M. Wallace asked the Minister for Health if his attention has been drawn to the fact that the North Eastern Health Board offered to facilitate the expansion of a region-wide breast cancer screening service in 1994; and the steps, if any, which have been taken by his Department to respond to this offer. [7806/95]
Limerick East): I propose to take Questions Nos. 60, 61, 62 and 66 together.
The Deputy will be aware that mammography screening involves the carrying out of mammography on a mass population basis to detect breast cancer in non symptomatic women. There is general agreement that mammography screening programmes are not effective in reducing mortality in younger women due to the density of breast tissue in this age group. For this reason, in cases of symptomatic younger women, a radiologist may recommend an ultrasound examination as an alternative to a mammogram and is generally more effective in this age group.
Consequently, mammography screening programmes tend to be directed at women aged between 50-65 years. There has been some debate regarding the effectiveness of mammography screening in reducing mortality from breast cancer. It is essential to establish whether a reduction in the mortality rate can be achieved in Ireland. For this reason, my Department has been supporting the Eccles Breast Screening Programme, which was one of a network of pilot schemes on breast cancer being carried out within the European Union.
The objectives of the Eccles Breast Screening Programme were:
—To evaluate the impact of mammographic screening on mortality from breast cancer among Irish women;
—To document compliance with a breast screening programme in Irish women;
—To compare the sensitivity, specificity and predictive value of the mammography programme with that reported internationally.